Solutions For RealSolutions For Real
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

4 Steps To Help You Decide Where To Live In Retirement

July 26, 2025

Just How Safe Is It to Charge Your Phone at the Airport?

July 26, 2025

The 10 Best-Paying Construction Jobs in America

July 26, 2025
Facebook Twitter Instagram
Trending
  • 4 Steps To Help You Decide Where To Live In Retirement
  • Just How Safe Is It to Charge Your Phone at the Airport?
  • The 10 Best-Paying Construction Jobs in America
  • 8 Hidden Dangers of Being “House Rich” and Cash Poor
  • 7 Signs You’re Building Wealth the Wrong Way
  • Stop Using ChatGPT Like an Amateur — Turn It Into a $100K Business Strategist
  • Why I Almost Always Choose Referrals When Hiring — And You Should Too
  • Mortgage rates inch lower this week
Saturday, July 26
Facebook Twitter Instagram
Solutions For RealSolutions For Real
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
Solutions For RealSolutions For Real
Home » Ozempic and Other Weight-Loss Drugs Have Pummeled This Stock. It May Be a Buy.
Investing

Ozempic and Other Weight-Loss Drugs Have Pummeled This Stock. It May Be a Buy.

News RoomBy News RoomSeptember 27, 20230 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

RBC Capital Markets analyst Nik Modi gives Utz a $17 price target.


Dreamstime

Utz Brands
stock has taken a hit this year, but one analyst says now is the time to buy shares of the snack maker.

RBC Capital Markets analyst Nik Modi initiated coverage of
Utz
stock (ticker: UTZ) with an Outperform rating and a $17 price target, implying a 25% increase to the stock’s Monday closing price. This bullish initiation comes after shares of the maker of potato chips, cheeseballs, pretzels, and more salty treats have dropped 13% this year.

One reason for Wall Street’s concern is the recent popularity of weight-loss drugs like Mounjaro, Ozempic, and Wegovy, and what that could mean for the snack food industry.
Novo Nordisk’s
(NVO) Ozempic and
Eli Lilly’s
(LLY) Mounjaro are two diabetes drugs being used by some for weight management. while Novo’s Wegovy has been approved for weight loss.

Modi wrote in a research note Tuesday that some investors are concerned by what the growing popularity of these drugs could mean for the stock, especially since they cause users to have a smaller appetite and require the people taking them to eat healthy foods to see results.

“We are not in this camp,” Modi said. “We must not forget that these drugs are expensive and out of reach for many Americans seeking to use them for weight loss as a result.”

“Consumption of indulgent salty snacks that would be considered ‘junk food’ generally over-indexes toward lower-income individuals, who are unlikely to be these drugs’ primary users,” the analyst added.

Modi also recognized that there are other concerns within the snack space as consumers continue to feel the pinch of high grocery prices as inflation runs hot. With prices historically high, shoppers may choose to trade down to store brands or avoid buying snacks altogether.

The analyst says these pressures will continue in the near term, but the stock is compelling for investors willing to wait.

“
Utz
is a pure-play salty snack company—which is one of the most attractive segments of the consumer-staples industry due to its faster growth, low exposure to private label and structural long-term drivers such as growth in smaller households and snacking extending to more occasions,” Modi said. “In addition, we believe Utz has significant opportunity to extend its geographic reach as its current sales base is concentrated in Northeast and Mid-Atlantic.”

Utz stock is rising 1.7% Tuesday to $13.80.

Write to Angela Palumbo at [email protected]

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

Why I Almost Always Choose Referrals When Hiring — And You Should Too

Investing July 26, 2025

Four-Day Workweek Study: Employees Happier, More Productive

Investing July 25, 2025

Her High School Side Hustle Is On Track for 7-Figure Revenue

Investing July 22, 2025

Why Most Startups Fail to Get National Press — and What To Do Instead

Investing July 18, 2025

Your Brand Isn’t Broken — Your PR Strategy Is. Here’s What to Do Instead

Investing July 16, 2025

13 Behaviors People Find Condescending

Investing July 15, 2025
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

Just How Safe Is It to Charge Your Phone at the Airport?

July 26, 20250 Views

The 10 Best-Paying Construction Jobs in America

July 26, 20250 Views

8 Hidden Dangers of Being “House Rich” and Cash Poor

July 26, 20250 Views

7 Signs You’re Building Wealth the Wrong Way

July 26, 20250 Views
Don't Miss

Stop Using ChatGPT Like an Amateur — Turn It Into a $100K Business Strategist

By News RoomJuly 26, 2025

Entrepreneur Most entrepreneurs think they’re using AI the right way — asking ChatGPT for catchy…

Why I Almost Always Choose Referrals When Hiring — And You Should Too

July 26, 2025

Mortgage rates inch lower this week

July 25, 2025

Finances Are Not The Only Factor When Deciding Where To Retire

July 25, 2025
About Us
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]

Our Picks

4 Steps To Help You Decide Where To Live In Retirement

July 26, 2025

Just How Safe Is It to Charge Your Phone at the Airport?

July 26, 2025

The 10 Best-Paying Construction Jobs in America

July 26, 2025
Most Popular

What Is ShopRunner?

March 1, 20251 Views

After This 29-Year-Old Got Hooked on ChatGPT, He Built a ‘Simple’ Side Hustle Around the Bot That Brings In $4,000 a Month Dhanvin Siriam wanted to build something that made revenue from ChatGPT, and once he did, he says, “It just caught on.”

December 19, 20231 Views

4 Steps To Help You Decide Where To Live In Retirement

July 26, 20250 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2025 Solutions For Real. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.